NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Journal of Clinical Investigation

Volumn 114, Issue 4, 2004, Pages 569-581

  Huber, Margit A ^a,b,c   Azoitei, Ninel ^a   Baumann, Bernd ^a   Grünert, Stefan ^b   Sommer, Andreas ^b   Pehamberger, Hubert ^c   Kraut, Norbert ^d   Beug, Hartmut ^b   Wirth, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

^b RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA; PROTEIN P21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; MESENCHYME; METASTASIS; MOUSE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; BREAST TUMOR; CANCER TRANSPLANTATION; CELL LINE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MESODERM; METABOLISM; NUDE MOUSE; PATHOLOGY; RETROVIRUS; TIME; TRANSPLANTATION; TUMOR CELL LINE; UDDER; VIRUS CELL TRANSFORMATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MESODERM; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; ONCOGENE PROTEIN P21(RAS); RETROVIRIDAE; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 4344612243     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421358     Document Type: Article

References (61)

1. Orlowski, R.Z., and Baldwin, A.S., Jr. 2002. NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8:385-389.
2. Karin, M., Cao, Y., Greten, F.R., and Li, Z.W. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer. 2:301-310.
3. Ghosh, S., May, M.J., and Kopp, E.B. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
4. Karin, M., and Ben-Neriah, Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
5. Gilmore, T.D. 1999. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogens. 18:6925-6937.
6. Cahir-McFarland, E.D., Izumi, K.M., and Mosialos, G. 1999. Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB. Oncogene. 18:6959-6964.
7. Sun, S.C. and Ballard, D.W. 1999. Persistent activation of NF-κB by the tax transforming protein of HTLV-1: hijacking cellular IκB kinases. Oncogene. 18:6948-6958.
8. Rayet, B., and Gelinas, C. 1999. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 18:6938-6947.
9. Bargou, R.C., et al. 1997. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:2961-2969.
10. Cabannes, E., Khan, G., Aillet, F., Jarrett, R.F., and Hay, R.T. 1999. Mutations in the IκBα gene in Hodgkin's disease suggest a tumour suppressor role for IκBα. Oncogene. 18:3063-3070.
11. Boyer, B., Valles, A.M., and Edme, N. 2000. Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60:1091-1099.
12. Thiery, J.P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2:442-454.
13. Thiery, J.P. 2003. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15:740-746.
14. Petersen, O.W., et al. 2003. Epithelial to mesenchymal transition in human breasr cancer can provide a nonmalignant stroma. Am. J. Pathol. 162:391-402.
15. Grünert, S., Jechlinger, M., and Beug, H. 2003. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4:657-665.
16. Hay, E.D. 1995. An overview of epithelio-mesenchymal transformation. Acta Anat. (Basel). 154:8-20.
17. Janda, E., et al. 2002. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299-313.
18. Jechlinger, M., et al. 2003. Expression profiling of epithelial plasticity in tumor progression. Oncogene. 22:7155-7169.
19. Oft, M., et al. 1996. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10:2462-2477.
20. Oft, M., Heider, K.H., and Beug, H. 1998. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8:1243-1252.
21. Lehmann, K., et al. 2000. Raf induces TGFβ production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14:2610-2622.
22. Ofr, M., Akhurst, R.J., and Balmain, A. 2002. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 4:487-494.
23. Gotzmann, J., et al. 2002. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J. Cell. Sci 115:1189-1202.
24. Dechend, R., et al. 1999. The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators. Oncogene. 18:3316-3323.
25. Cogswell, P.C., Guttridge, D.C., Funkhouser, W.K., and Baldwin, A.S., Jr. 2000. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene. 19:1123-1131.
26. Adolph, K.W., Liska, D.J., and Bornstein, P. 1997. Analysis of the promoter and transcription start sites of the human thrombospondin 2 gene (THBS2). Gene. 193:5-11.
27. Pahl, H.L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 18:6853-6866.
28. Arsura, M., et al. 2003. Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene. 22:412-425.
29. Huber, M.A., et al. 2002. The IKK-2/IκBα/ NF-κB pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in IκBα-deficient mice. J. Biol. Chem. 277:1268-1275.
30. Kucharczak, J., Simmons, M.J., Fan, Y., and Gelinas, C. 2003. To be, or not to be: NF-κB is the answer - role of Rel/NF-κB in the regulation of apoptosis. Oncogene. 22:8961-8982.
31. Wang, C.Y, Cusack, J.C., Jr., Liu, R., and Baldwin, A.S., Jr. 1999. Control of inducible chemo-resistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med. 5:412-417.
32. Cusack, J.C., Jr., Liu, R., and Baldwin, A.S., Jr. 2000. Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]- carbonyloxycamptothecin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-κB activation. Cancer Res. 60:2323-2330.
33. Nakshatri, H., Bhat-Nakshatri, P., Martin, D.A., Goulet, R.J., Jr., and Sledge, G.W., Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629-3639.
34. Sovak, M.A., et al. 1997. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:2952-2960.
35. Romieu-Mourez, R., et al. 2001. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-κB in breast cancer. Cancer Res. 61:3810-3818.
36. Romieu-Mourez, R., et al. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23:5738-5754.
37. Huang, S., Pettaway, C.A., Uehara, H., Bucana, C.D., and Fidler, I.J. 2001. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene. 20:4188-4197.
38. Helbig, G., et al. 2003. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278:21631-21638
39. Huang, S., DeGuzman, A., Bucana, C.D., and Fidler, I.J. 2000. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res. 6:2573-2581.
40. Andela, V.B., Schwarz, E.M., Puzas, J.E., O'Keefe, R.J., and Rosier, R.N. 2000. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappa B. Cancer Res. 60:6557-6562.
41. Dajee, M., et al. 2003. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 421:639-643.
42. Romashkova, J.A., and Makarov, S.S. 1999. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 401:86-90.
43. Kane, L.P., Shapiro, V.S., Stokoe, D., and Weiss, A. 1999. Induction of NF-κB by the Akt/PKB kinase. Curr. Biol. 9:601-604.
44. Ozes, O.N., et al. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:82-85.
45. Madrid, L.V., Mayo, M.W., Reuther, J.Y., and Baldwin, A.S., Jr. 2001. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:18934-18940.
46. Lopez-Rovira, T., Chalaux, E., Rosa, J.L., Bartrons, R., and Ventura, F. 2000. Interaction and functional cooperation of NF-κB with Smads. Transcriptional regulation of the junB promoter. J. Biol. Chem. 275:28937-28946.
47. Seoane, J., Le, H.-V., Shen, L., Anderson, S.A., and Massague, J. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 117:211-223.
48. Brunet, A., et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 96:857-868.
49. Hu, M.C.-T., et al. 2004. IκB kinase promotes tumorigenesis through inhibition of forkhead FoxO3a. Cell. 117:225-237.
50. Lilienbaum, A., Duc Dodon, M., Alexandre, C., Gazzolo, L., and Paulin, D. 1990. Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J. Virol. 64:256-263.
51. Li, X., et al. 2002. IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J. Biol. Chem. 277:45129-45140.
52. Katsel, P.L., and Greenstein, R.J. 2001. Identification of overlapping AP-2/NF-κB-responsive elements on the rat cholecystokinin gene promoter. J. Biol. Chem. 276:752-758.
53. Ueda, A., et al. 1994. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153:2052-2063.
54. Liacini, A., et al. 2003. Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondrocytes. Exp. Cell Res. 288:208-217.
55. Mettouchi, A., et al. 1997. The c-Jun-induced transformation process involves complex regulation of tenascin-C expression. Mol. Cell. Biol. 17:3202-3209.
56. Tian, B., and Brasier, A.R. 2003. Identification of a nuclear factor κB-dependent gene network. Recent Prog. Horm. Res. 58:95-130.
57. Philip, S., Bulbule, A., and Kundou, G.C. 2001. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κB-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J. Biol. Chem. 276:44926-44935.
58. Israel, A., et al. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8:3793-3800.
59. Israel, A., Yano, O., Logeat, F., Kieran, M., and Kourilsky, P. 1989. Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells. Nucleic Acids Res. 17:5245-5257.
60. Bitko, V., Velazquez, A., Yang, L., Yang, Y.C., and Barik, S. 1997. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-κB and is inhibited by sodium salicylate and aspirin. Virology. 232:369-378.
61. Ohmori, Y., Fukumoto, S., and Hamilton, T.A. 1995. Two structurally distinct kappa B sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J. Immunol. 155:3593-3600.